1 / 11

Collaborative Clinical Medicines Procurement

Collaborative Clinical Medicines Procurement. Procurement & Distribution Interest Group Autumn Symposium: 11 th November 2010 Dr Anthony Grosso Formulary & Medicines Management Pharmacist anthony.grosso@uclh.nhs.uk. Outline. Getting value for money: Outline. The past… The present…

Télécharger la présentation

Collaborative Clinical Medicines Procurement

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Collaborative Clinical Medicines Procurement Procurement & Distribution Interest Group Autumn Symposium: 11th November 2010 Dr Anthony Grosso Formulary & Medicines Management Pharmacist anthony.grosso@uclh.nhs.uk

  2. Outline

  3. Getting value for money: Outline The past… The present… The future… Key messages

  4. Proactive • Progressive • Savings ++ • Particularly effective for generic medicines The past: NHS Procurement

  5. The past…NHS Clinical Passive & reactive initially Through collaboration: increased activity Statin project: key milestone

  6. Medicine savings pathway: example Opportunity identified by procurement: PREDICTED price drop Opportunity assessed by clinical Jointly scoped estimated savings per scenario Stakeholder consultation Modifications Barriers identified Clinical evaluation Implementation Marketing & counter-marketing strategy employed Tracking & continual management

  7. The present… - Active collaboration between procurement & clinical Opportunities identified by procurement – feasibility-tested and implementation led by clinical - Opportunities identified by clinical - forensic examination of individual drug use and discrete therapeutic pathways

  8. Targets & Implementation Allows for generation of multiple targets & savings ++ Rank by level of saving vs. degree of effort Austerity – aids implementation! Proven track record e.g. Statins, ARBs, anti-TNFs, Growth Hormones, 5-ASAs, GCSFs, 5-HT3s etc…

  9. The Future Increased clinical input into procurement groups Further adaptation required 2013 + (White paper, PPRS, VBP,NICE/NPC)

  10. Key messages: NHS Clinical + procurement specialists: collaborate more closely to generate greater opportunities for saving money Innovate: look beyond price differences e.g. homecare savings Designate more time & resource to implementation activities Share ideas among colleagues

  11. Key messages: Pharma Threats & opportunities Must adapt accordingly Collaborate with clinical-procurement groups Develop innovative ideas that are mutually beneficial Motivate decision-makers and influencers WITHIN the NHS to actively market your product for you!

More Related